^ Skid has most of my thoughts here. I'd be viewing this as a speculative 'startup' type bet considering where it appears their business plan is at the moment. From the info sheet it appears AFT was cash +ve (sustainable growth) then did a big drive into Oz which increased rev but at a loss. I think their details around growing their global market are also bit sparse.

Be interested to see what their GM is (cant find anything in that info sheet), generic drugs are typically low margin plus coupled with the fact they use contract manufacturers (likely Douglas, GMP etc) I cant imagine there is alot of meat left.

DYOR but I'd ask alot more questions on this one before plunging in.